A long-term comparison of proquazone and naproxen in the treatment of osteoarthritis of the hip. 1978

J T Vainio, and P V Lepistö

The efficacy and tolerance of 900 mg/day proquazone were compared with those of 500 mg/day naproxen in a three-month trial with 40 patients suffering from osteoarthritis of the hip. Proquazone was found to be more effective than naproxen in providing relief of symptoms and improving the patient's condition. The side effects of proquazone were exclusively gastrointestinal but occurred more frequently than with naproxen. With one exception, none of the symptoms were serious enough to require suspension of therapy. These results suggest that the action of proquazone provides a good balance between clinical efficacy and tolerance.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009288 Naproxen An anti-inflammatory agent with analgesic and antipyretic properties. Both the acid and its sodium salt are used in the treatment of rheumatoid arthritis and other rheumatic or musculoskeletal disorders, dysmenorrhea, and acute gout. Aleve,Anaprox,Methoxypropiocin,Naprosin,Naprosyn,Naproxen Sodium,Proxen,Sodium Naproxenate,Synflex,Naproxenate, Sodium,Sodium, Naproxen
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006621 Hip Joint The joint that is formed by the articulation of the head of FEMUR and the ACETABULUM of the PELVIS. Acetabulofemoral Joint,Acetabulofemoral Joints,Hip Joints,Joint, Acetabulofemoral,Joint, Hip,Joints, Acetabulofemoral,Joints, Hip
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J T Vainio, and P V Lepistö
October 1977, Therapeutische Umschau. Revue therapeutique,
J T Vainio, and P V Lepistö
August 1981, Rheumatology and rehabilitation,
J T Vainio, and P V Lepistö
January 1978, Scandinavian journal of rheumatology. Supplement,
J T Vainio, and P V Lepistö
January 1981, European journal of rheumatology and inflammation,
J T Vainio, and P V Lepistö
January 1978, The Journal of rheumatology,
J T Vainio, and P V Lepistö
May 1983, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
J T Vainio, and P V Lepistö
January 1980, The Journal of rheumatology,
J T Vainio, and P V Lepistö
July 1985, The British journal of clinical practice,
Copied contents to your clipboard!